Annexon, Inc.
- Last sale
- Nov 6, 2026 · +4.75%
- Market cap
- $625.83M
- 149.36M shares
- Filings
- 524
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+227.4% FY25 yoy
- $625.83M
- —
- —
- 4.4×
- -29.80%
- —
FY2025 figures · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $184,698,000 | reported | |
| FY 2024 | 2024-12-31 | $119,448,000 | reported | |
| FY 2023 | 2023-12-31 | $113,756,000 | reported | |
| FY 2022 | 2022-12-31 | $112,501,000 | reported | |
| FY 2021 | 2021-12-31 | $100,066,000 | reported | |
| FY 2020 | 2020-12-31 | $49,271,000 | reported | |
| FY 2019 | 2019-12-31 | $24,524,000 | reported |
Pharmaceutical preparations
Annexon, Inc. is the 174th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CLYMClimb Bio, Inc.———$638.2MGERNGeron Corp———$636.4MACRSAclaris Therapeutics, Inc.$7.8M58.2%829.6%$635.2MQNRXQuoin Pharmaceuticals Ltd.———$628.9M
ANNXAnnexon, Inc. (this company)———$625.8M
WVEWave Life Sciences, Inc.$42.7M60.5%478.3%$622.3MABUSArbutus Biopharma Corp$14.1M128.2%237.9%$617.8MIVAInventiva S.A.Fiscal 2021 figures———$604.8MEVOEvotec SE———$595.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Annexon, Inc. · CIK 1528115 · Engraved from SEC EDGAR